DHP-Ca ++ -Antagonisten:
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Book |
| Language: | German |
| Published: |
München
Arcis-Verl.
1994
|
| Series: | Herz-Kreislauf-Information
|
| Subjects: | |
| Item Description: | Enth. u.a.: Bedeutung myogener Mechanismen bei der Kontrolle des peripheren Gefäßwiderstandes / Börje Johansson. Modip, galenische und biopharmazeutische Optimierung des Dihydropyridins (Calciumantagonisten) Felodipin / Bernhard Christian Lippold. - Literaturangaben |
| Physical Description: | 67 S. Ill., graph. Darst. |
| ISBN: | 3890750788 |
Staff View
MARC
| LEADER | 00000nam a2200000 c 4500 | ||
|---|---|---|---|
| 001 | BV009955913 | ||
| 003 | DE-604 | ||
| 005 | 20021203 | ||
| 007 | t | ||
| 008 | 941220s1994 ad|| |||| 00||| ger d | ||
| 020 | |a 3890750788 |9 3-89075-078-8 | ||
| 035 | |a (OCoLC)39093969 | ||
| 035 | |a (DE-599)BVBBV009955913 | ||
| 040 | |a DE-604 |b ger |e rakddb | ||
| 041 | 0 | |a ger | |
| 049 | |a DE-12 |a DE-19 | ||
| 245 | 1 | 0 | |a DHP-Ca ++ -Antagonisten |
| 246 | 1 | 3 | |a DHP-CA-Antagonisten |
| 264 | 1 | |a München |b Arcis-Verl. |c 1994 | |
| 300 | |a 67 S. |b Ill., graph. Darst. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 0 | |a Herz-Kreislauf-Information | |
| 500 | |a Enth. u.a.: Bedeutung myogener Mechanismen bei der Kontrolle des peripheren Gefäßwiderstandes / Börje Johansson. Modip, galenische und biopharmazeutische Optimierung des Dihydropyridins (Calciumantagonisten) Felodipin / Bernhard Christian Lippold. - Literaturangaben | ||
| 650 | 4 | |a Calcium Channel Blockers |x pharmacology | |
| 650 | 4 | |a Dihydropyridines |x pharmacology | |
| 650 | 0 | 7 | |a Felodipin |0 (DE-588)4251918-4 |2 gnd |9 rswk-swf |
| 689 | 0 | 0 | |a Felodipin |0 (DE-588)4251918-4 |D s |
| 689 | 0 | |5 DE-604 | |
| 700 | 1 | 2 | |a Johansson, Börje |4 aut |t Bedeutung myogener Mechanismen bei der Kontrolle des peripheren Gefäßwiderstandes |
| 700 | 1 | 2 | |a Lippold, Bernhard C. |4 aut |t Modip, galenische und biopharmazeutische Optimierung des Dihydropyridins (Calciumantagonisten) Felodipin |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-006597894 | ||
Record in the Search Index
| _version_ | 1804124327020331008 |
|---|---|
| any_adam_object | |
| author | Johansson, Börje Lippold, Bernhard C. |
| author_facet | Johansson, Börje Lippold, Bernhard C. |
| author_role | aut aut |
| author_sort | Johansson, Börje |
| author_variant | b j bj b c l bc bcl |
| building | Verbundindex |
| bvnumber | BV009955913 |
| ctrlnum | (OCoLC)39093969 (DE-599)BVBBV009955913 |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01504nam a2200361 c 4500</leader><controlfield tag="001">BV009955913</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20021203 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">941220s1994 ad|| |||| 00||| ger d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">3890750788</subfield><subfield code="9">3-89075-078-8</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)39093969</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV009955913</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">ger</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-12</subfield><subfield code="a">DE-19</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">DHP-Ca ++ -Antagonisten</subfield></datafield><datafield tag="246" ind1="1" ind2="3"><subfield code="a">DHP-CA-Antagonisten</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">München</subfield><subfield code="b">Arcis-Verl.</subfield><subfield code="c">1994</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">67 S.</subfield><subfield code="b">Ill., graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Herz-Kreislauf-Information</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Enth. u.a.: Bedeutung myogener Mechanismen bei der Kontrolle des peripheren Gefäßwiderstandes / Börje Johansson. Modip, galenische und biopharmazeutische Optimierung des Dihydropyridins (Calciumantagonisten) Felodipin / Bernhard Christian Lippold. - Literaturangaben</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Calcium Channel Blockers</subfield><subfield code="x">pharmacology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Dihydropyridines</subfield><subfield code="x">pharmacology</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Felodipin</subfield><subfield code="0">(DE-588)4251918-4</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Felodipin</subfield><subfield code="0">(DE-588)4251918-4</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2="2"><subfield code="a">Johansson, Börje</subfield><subfield code="4">aut</subfield><subfield code="t">Bedeutung myogener Mechanismen bei der Kontrolle des peripheren Gefäßwiderstandes</subfield></datafield><datafield tag="700" ind1="1" ind2="2"><subfield code="a">Lippold, Bernhard C.</subfield><subfield code="4">aut</subfield><subfield code="t">Modip, galenische und biopharmazeutische Optimierung des Dihydropyridins (Calciumantagonisten) Felodipin</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-006597894</subfield></datafield></record></collection> |
| id | DE-604.BV009955913 |
| illustrated | Illustrated |
| indexdate | 2024-07-09T17:43:54Z |
| institution | BVB |
| isbn | 3890750788 |
| language | German |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-006597894 |
| oclc_num | 39093969 |
| open_access_boolean | |
| owner | DE-12 DE-19 DE-BY-UBM |
| owner_facet | DE-12 DE-19 DE-BY-UBM |
| physical | 67 S. Ill., graph. Darst. |
| publishDate | 1994 |
| publishDateSearch | 1994 |
| publishDateSort | 1994 |
| publisher | Arcis-Verl. |
| record_format | marc |
| series2 | Herz-Kreislauf-Information |
| spelling | DHP-Ca ++ -Antagonisten DHP-CA-Antagonisten München Arcis-Verl. 1994 67 S. Ill., graph. Darst. txt rdacontent n rdamedia nc rdacarrier Herz-Kreislauf-Information Enth. u.a.: Bedeutung myogener Mechanismen bei der Kontrolle des peripheren Gefäßwiderstandes / Börje Johansson. Modip, galenische und biopharmazeutische Optimierung des Dihydropyridins (Calciumantagonisten) Felodipin / Bernhard Christian Lippold. - Literaturangaben Calcium Channel Blockers pharmacology Dihydropyridines pharmacology Felodipin (DE-588)4251918-4 gnd rswk-swf Felodipin (DE-588)4251918-4 s DE-604 Johansson, Börje aut Bedeutung myogener Mechanismen bei der Kontrolle des peripheren Gefäßwiderstandes Lippold, Bernhard C. aut Modip, galenische und biopharmazeutische Optimierung des Dihydropyridins (Calciumantagonisten) Felodipin |
| spellingShingle | Johansson, Börje Lippold, Bernhard C. DHP-Ca ++ -Antagonisten Calcium Channel Blockers pharmacology Dihydropyridines pharmacology Felodipin (DE-588)4251918-4 gnd |
| subject_GND | (DE-588)4251918-4 |
| title | DHP-Ca ++ -Antagonisten |
| title_alt | DHP-CA-Antagonisten Bedeutung myogener Mechanismen bei der Kontrolle des peripheren Gefäßwiderstandes Modip, galenische und biopharmazeutische Optimierung des Dihydropyridins (Calciumantagonisten) Felodipin |
| title_auth | DHP-Ca ++ -Antagonisten |
| title_exact_search | DHP-Ca ++ -Antagonisten |
| title_full | DHP-Ca ++ -Antagonisten |
| title_fullStr | DHP-Ca ++ -Antagonisten |
| title_full_unstemmed | DHP-Ca ++ -Antagonisten |
| title_short | DHP-Ca ++ -Antagonisten |
| title_sort | dhp ca antagonisten |
| topic | Calcium Channel Blockers pharmacology Dihydropyridines pharmacology Felodipin (DE-588)4251918-4 gnd |
| topic_facet | Calcium Channel Blockers pharmacology Dihydropyridines pharmacology Felodipin |
| work_keys_str_mv | AT johanssonborje dhpcaantagonisten AT lippoldbernhardc dhpcaantagonisten |